B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation

REACTOME PATHWAY
Reactome: R-HSA-9751444 genes18 compounds

The IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation pathway (Reactome ID: R-HSA-975144) involves 4 genes and is affected by 18 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CHUKIKBKBIRAK1UBE2N

Compounds Affecting IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation

#CompoundTargets HitStudies
1Crizotinib298
2alsterpaullone12
3chicoric acid117
4naringin300
5Chlorhexidine299
6Perphenazine297
7Sphingosine300
8Resveratrol298
9Sertraline1,000
10Astemizole Antihistamine drug now withdrawn from280
11Canrenone300
12Thioridazine35
13Afatinib297
14Axitinib298
15Sorafenib300
16Aurintricarboxylic Acid184
17sp600125117
18glaucarubinone10

About the IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation Pathway

The IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation pathway is catalogued in Reactome (ID: R-HSA-975144) and involves 4 genes. In the BiohacksAI corpus, 18 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CHUK, IKBKB, IRAK1, UBE2N.